Tumor characteristics and oncological outcome after radical prostatectomy in men 75 years and older.

PUROSE - As life expectancy increases, oncological outcome in elderly patients ≥75 years is a salient topic requiring further investigation.

MATERIALS AND METHODS - A total of 13997 patients who underwent RP from 2006 to 2013 were analyzed.

Known prognosticators were compared according to patient age at RP (13732 patients<75 years versus 265 patients≥75 years). Uni- and multivariate Cox regressions were used to estimate the impact of age on biochemical recurrence (BCR)-free survival, metastasis-free survival (MFS), cancer-specific survival (CSS) and overall survival (OS) RESULTS: Median follow up was 47. 3 months. Patients ≥75 years compared to patients <75 years had a higher pathologic Gleason score (p<0. 001), were more likely to harbor non-organ-confined tumor (p<0. 001), to have positive surgical margin (p=0. 004) and positive lymph nodes (p=0. 028) and to receive salvage ADT (p=0. 002). 5-year BCR-free survival, MFS, CSS and overall survival were 64. 2%, 84. 7%, 98. 4% and 91. 3% for patients ≥75 years and 76. 9%, 96. 2%, 99. 0% and 96. 2% for patients <75 years. In uni- and multivariate analysis age ≥75 was associated with a worse BCR-free survival and MFS. Patients ≥75 years were more likely to die from other causes than cancer. Nevertheless non-cancer related mortality was very low.

CONCLUSIONS - Older patients who underwent RP had more advanced disease. Age itself is an independent predictor of worse BCR-free and MFS. Healthy and highly selected patients ≥75 years in our sample showed good long-term overall survival. Therefore, older age in well selected men should not be a contraindication for RP, especially in patients harboring high-risk disease.

The Journal of urology. 2016 Jan 18 [Epub ahead of print]

Philipp Mandel, Maximilian C Kriegmair, Janneke Kleine Kamphake, Felix K-H Chun, Markus Graefen, Hartwig Huland, Derya Tilki

Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. , Department of Urology, University Medical Centre Mannheim, Mannheim, Germany. , Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. , Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. , Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. , Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. , Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.  

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe